Week in Review: Hepalink Invests $13 Million in Canada's OncoQuest
November 29, 2015 at 03:52 AM EST
Shenzhen Hepalink Pharma closed a $13 million investment in OncoQuest, the oncology subsidiary of Canada's Quest PharmaTech giving Hepalink a 42% stake in OncoQuest.
